March 7, 2026
Headlines

Demystifying Beam Therapeutics: Insights From 4 Analyst Reviews

Sumain Faisal01 mins

Latest Ratings for BEAM

Date Firm Action From To
Jan 2022 SVB Leerink Maintains Outperform
Jan 2022 Guggenheim Initiates Coverage On Buy
Nov 2021 SVB Leerink Maintains Outperform

View More Analyst Ratings for BEAM

View the Latest Analyst Ratings

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News